D Molecular Therapeutics, Inc.’s FDMT share price has dipped by 5.25%, which has investors questioning if this is right time to buy.

A viral video featuring Eric Schmidt warns that AIs soaring energy demands could soon overwhelm Americas outdated power grid.

Established enterprise tech providers that aren’t cloud giants are getting serious about AI agents too. IBM, for one, ...